​

Fortress Biotech (FBIO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

FBIO Stock Forecast

Fortress Biotech (FBIO) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $5.00 and a low of $5.00. This represents a 81.16% increase from the last price of $2.76.

High: $5 Avg: $5 Low: $5 Last Closed Price: $2.76

FBIO Stock Rating

Fortress Biotech stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 6 Strong Sell Sell Hold Buy Strong Buy

FBIO Price Target Upside V Benchmarks

TypeNameUpside
StockFortress Biotech81.16%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts111
Avg Price Target$5.00$5.00$5.00
Last Closing Price$2.76$2.76$2.76
Upside/Downside81.16%81.16%81.16%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 26-2---2
May, 26-2---2
Apr, 26-2---2
Mar, 26-2---2
Feb, 26-2---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 18, 2026Industrial Alliance Securities$5.00$2.5596.08%81.16%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 18, 2026CitigroupBuyBuyhold
Apr 09, 2024H.C. WainwrightBuyBuyhold
Jul 14, 2022B. Riley SecuritiesBuyBuyhold
Apr 26, 2022Zacks Investment ResearchStrong Selldowngrade

Financial Forecast

EPS Forecast

$-20 $-15 $-10 $-5 $0 $5 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-11.85$-14.55$-8.47$-2.69$-0.07--
Avg Forecast$-5.50$-13.13$-7.75$-3.51$-1.48$-0.42$-0.46
High Forecast$-4.07$-9.70$-5.42$-2.45$-1.14$0.23$-0.32
Low Forecast$-6.93$-16.55$-10.20$-4.62$-1.81$-1.07$-0.61
Surprise %115.45%10.81%9.29%-23.36%-95.27%--

Revenue Forecast

$50M $90M $130M $170M $210M $250M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$68.79M$75.74M$84.51M$57.67M$61.24M--
Avg Forecast$89.50M$77.97M$79.70M$58.87M$134.53M$198.39M$198.80M
High Forecast$107.35M$93.61M$99.15M$59.30M$156.02M$246.81M$247.32M
Low Forecast$71.65M$62.33M$61.27M$58.42M$113.04M$152.53M$152.84M
Surprise %-23.14%-2.86%6.04%-2.02%-54.48%--

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-64.70M$-86.58M$-60.64M$-46.00M$-32.91M--
Avg Forecast$-44.61M$-106.46M$-68.67M$-28.68M$-11.98M$-3.41M$-3.76M
High Forecast$-33.05M$-78.70M$-43.94M$-19.89M$-9.26M$1.87M$-2.61M
Low Forecast$-56.17M$-134.21M$-82.75M$-37.47M$-14.69M$-8.68M$-4.91M
Surprise %45.04%-18.68%-11.70%60.38%174.80%--

FBIO Forecast FAQ

Is Fortress Biotech stock a buy?

Fortress Biotech stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Fortress Biotech is a favorable investment for most analysts.

What is Fortress Biotech's price target?

Fortress Biotech's price target, set by 6 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $5 at the low end to $5 at the high end, suggesting a potential 81.16% change from the previous closing price of $2.76.

How does Fortress Biotech stock forecast compare to its benchmarks?

Fortress Biotech's stock forecast shows a 81.16% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Fortress Biotech over the past three months?

  • June 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Fortress Biotech’s EPS forecast?

Fortress Biotech's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.42, marking a 500.00% increase from the reported $-0.07 in 2025. Estimates for the following years are.

What is Fortress Biotech’s revenue forecast?

Fortress Biotech's average annual revenue forecast for its fiscal year ending in December 2026 is $198.39M, reflecting a 223.96% increase from the reported $61.24M in 2025. The forecast for.

What is Fortress Biotech’s net income forecast?

Fortress Biotech's net income forecast for the fiscal year ending in December 2026 stands at $-3.407M, representing a -89.65% decrease from the reported $-32.915M in 2025. Projections indicate .